Clinical Trial: A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07688772) titled 'A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis' on June 26.

Brief Summary: This study is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial aimed at evaluating the efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of SHR-1819 injection in patients with Seasonal Allergic Rhinitis (SAR).

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Seasonal Allergic Rhinitis

Intervention: DRUG: SHR-1819 Injection

SHR-1819 injection.

DRUG: SHR-1819 Injection Placebo

SHR-1819 injection pl...